Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2019

Open Access 01-12-2019 | Bone Defect | Research article

Autologous cell-coated particles for the treatment of segmental bone defects—a new cell therapy approach

Authors: Dror Ben-David, Bettina Fishman, Guy Rubin, Atara Novak, Ilana Laevsky, Avinoam Kadouri, Yasmin Nishri Katz, Ora Burger, Asaph Zaretsky, Noam Bor, Ephraim Tzur, Shai Meretzki, Nimrod Rozen

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2019

Login to get access

Abstract

Background

Adipose tissue-derived mesenchymal stem cells (AT-MSCs) are one of the most potent adult stem cells, capable of differentiating into bone, cartilage, adipose, muscle, and others. An innovative autologous AT-MSC-derived cell-based product (BonoFill-II) for bone tissue regeneration was developed to be suited as a bone graft for segmental bone defects.

Methods

BonoFill-II was transplanted into 8 sheep with 3.2-cm full cortex segmental defect formed in the tibia. Bone regeneration was followed by X-ray radiographs for 12 weeks. At experiment termination, the healed tibia bones were analyzed by computed tomography, histology, and mechanical tests.

Results

Our results indicate that one dose of BonoFill-II injectable formula led to an extensive bone growth within the transplantation site and to a complete closure of the critical gap in the sheep’s tibia in a relatively short time (8–12 weeks), with no inflammation and no other signs of graft rejection. This new and innovative product opens new prospects for the treatment of long bone defects.

Conclusions

Injection of BonoFill-II (an innovative autologous cell therapy product for bone tissue regeneration) into a critical size segmental defect model (3.2 cm), generated in the sheep tibia, achieved full bridging of the gap in an extremely short period (8–12 weeks).
Literature
1.
go back to reference Bhandari M, Guyatt GH, Tornetta P 3rd, Swiontkowski MF, Hanson B, Sprague S, et al. Current practice in the intramedullary nailing of tibial shaft fractures: an international survey. J Trauma. 2002;53(4):725–32.PubMedCrossRef Bhandari M, Guyatt GH, Tornetta P 3rd, Swiontkowski MF, Hanson B, Sprague S, et al. Current practice in the intramedullary nailing of tibial shaft fractures: an international survey. J Trauma. 2002;53(4):725–32.PubMedCrossRef
3.
go back to reference Bertolai R, Catelani C, Aversa A, Rossi A, Giannini D, Bani D. Bone graft and mesenchimal stem cells: clinical observations and histological analysis. Clin Cases Miner Bone Metab. 2015;12(2):183–7.PubMedPubMedCentral Bertolai R, Catelani C, Aversa A, Rossi A, Giannini D, Bani D. Bone graft and mesenchimal stem cells: clinical observations and histological analysis. Clin Cases Miner Bone Metab. 2015;12(2):183–7.PubMedPubMedCentral
4.
go back to reference Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42(Suppl 2):S3–15.PubMedCrossRef Dimitriou R, Mataliotakis GI, Angoules AG, Kanakaris NK, Giannoudis PV. Complications following autologous bone graft harvesting from the iliac crest and using the RIA: a systematic review. Injury. 2011;42(Suppl 2):S3–15.PubMedCrossRef
5.
go back to reference Park JJ, Hershman SH, Kim YH. Updates in the use of bone grafts in the lumbar spine. Bull Hosp Jt Dis (2013). 2013;71(1):39–48. Park JJ, Hershman SH, Kim YH. Updates in the use of bone grafts in the lumbar spine. Bull Hosp Jt Dis (2013). 2013;71(1):39–48.
6.
go back to reference Baumhauer J, Pinzur MS, Donahue R, Beasley W, DiGiovanni C. Site selection and pain outcome after autologous bone graft harvest. Foot Ankle Int. 2014;35(2):104–7.PubMedCrossRef Baumhauer J, Pinzur MS, Donahue R, Beasley W, DiGiovanni C. Site selection and pain outcome after autologous bone graft harvest. Foot Ankle Int. 2014;35(2):104–7.PubMedCrossRef
7.
go back to reference Aponte-Tinao LA, Ayerza MA, Muscolo DL, Farfalli GL. What are the risk factors and management options for infection after reconstruction with massive bone allografts? Clin Orthop Relat Res. 2016;474(3):669–73.PubMedCrossRef Aponte-Tinao LA, Ayerza MA, Muscolo DL, Farfalli GL. What are the risk factors and management options for infection after reconstruction with massive bone allografts? Clin Orthop Relat Res. 2016;474(3):669–73.PubMedCrossRef
8.
go back to reference Ehrler DM, Vaccaro AR. The use of allograft bone in lumbar spine surgery. Clin Orthop Relat Res. 2000;371:38–45.CrossRef Ehrler DM, Vaccaro AR. The use of allograft bone in lumbar spine surgery. Clin Orthop Relat Res. 2000;371:38–45.CrossRef
9.
go back to reference Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.PubMedCrossRef Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.PubMedCrossRef
10.
go back to reference Choi JW, Park EJ, Shin HS, Shin IS, Ra JC, Koh KS. In vivo differentiation of undifferentiated human adipose tissue-derived mesenchymal stem cells in critical-sized calvarial bone defects. Ann Plast Surg. 2014;72(2):225–33.PubMedCrossRef Choi JW, Park EJ, Shin HS, Shin IS, Ra JC, Koh KS. In vivo differentiation of undifferentiated human adipose tissue-derived mesenchymal stem cells in critical-sized calvarial bone defects. Ann Plast Surg. 2014;72(2):225–33.PubMedCrossRef
12.
go back to reference Lian JB, Stein GS. Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J. 1995;15:118–40.PubMedPubMedCentral Lian JB, Stein GS. Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J. 1995;15:118–40.PubMedPubMedCentral
14.
go back to reference Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693.PubMedPubMedCentralCrossRef Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693.PubMedPubMedCentralCrossRef
15.
go back to reference Griffin M, Kalaskar DM, Butler PE, Seifalian AM. The use of adipose stem cells in cranial facial surgery. Stem Cell Rev. 2014;10(5):671–85.PubMedCentralCrossRef Griffin M, Kalaskar DM, Butler PE, Seifalian AM. The use of adipose stem cells in cranial facial surgery. Stem Cell Rev. 2014;10(5):671–85.PubMedCentralCrossRef
17.
go back to reference Christou C, Oliver RA, Pelletier MH, Walsh WR. Ovine model for critical-size tibial segmental defects. Comp Med. 2014;64(5):377–85.PubMedPubMedCentral Christou C, Oliver RA, Pelletier MH, Walsh WR. Ovine model for critical-size tibial segmental defects. Comp Med. 2014;64(5):377–85.PubMedPubMedCentral
18.
go back to reference Pneumaticos SG, Triantafyllopoulos GK, Basdra EK, Papavassiliou AG. Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments. J Cell Mol Med. 2010;14(11):2561–9.PubMedPubMedCentralCrossRef Pneumaticos SG, Triantafyllopoulos GK, Basdra EK, Papavassiliou AG. Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments. J Cell Mol Med. 2010;14(11):2561–9.PubMedPubMedCentralCrossRef
19.
go back to reference Martini L, Fini M, Giavaresi G, Giardino R. Sheep model in orthopedic research: a literature review. Comp Med. 2001;51(4):292–9.PubMed Martini L, Fini M, Giavaresi G, Giardino R. Sheep model in orthopedic research: a literature review. Comp Med. 2001;51(4):292–9.PubMed
20.
go back to reference Rozen N, Bick T, Bajayo A, Shamian B, Schrift-Tzadok M, Gabet Y, et al. Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone. 2009;45(5):918–24.PubMedCrossRef Rozen N, Bick T, Bajayo A, Shamian B, Schrift-Tzadok M, Gabet Y, et al. Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone. 2009;45(5):918–24.PubMedCrossRef
21.
go back to reference Gregory P, Sanders R. The treatment of closed, unstable tibial shaft fractures with unreamed interlocking nails. Clin Orthop Relat Res. 1995;315:48–55. Gregory P, Sanders R. The treatment of closed, unstable tibial shaft fractures with unreamed interlocking nails. Clin Orthop Relat Res. 1995;315:48–55.
22.
go back to reference Grayson WL, Bunnell BA, Martin E, Frazier T, Hung BP, Gimble JM. Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol. 2015;11(3):140–50.PubMedPubMedCentralCrossRef Grayson WL, Bunnell BA, Martin E, Frazier T, Hung BP, Gimble JM. Stromal cells and stem cells in clinical bone regeneration. Nat Rev Endocrinol. 2015;11(3):140–50.PubMedPubMedCentralCrossRef
23.
go back to reference Wegman F, Bijenhof A, Schuijff L, Oner FC, Dhert WJ, Alblas J. Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur Cell Mater. 2011;21:230–42 discussion 42.PubMedCrossRef Wegman F, Bijenhof A, Schuijff L, Oner FC, Dhert WJ, Alblas J. Osteogenic differentiation as a result of BMP-2 plasmid DNA based gene therapy in vitro and in vivo. Eur Cell Mater. 2011;21:230–42 discussion 42.PubMedCrossRef
24.
go back to reference Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Current Opinion in Orthopaedics. 2007;18(5):444–8.CrossRef Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Current Opinion in Orthopaedics. 2007;18(5):444–8.CrossRef
26.
go back to reference Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45–54.PubMedCrossRef Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45–54.PubMedCrossRef
27.
go back to reference Sen MK, Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? Injury. 2007;38(Suppl 1):S75–80.PubMedCrossRef Sen MK, Miclau T. Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions? Injury. 2007;38(Suppl 1):S75–80.PubMedCrossRef
28.
go back to reference Campana V, Milano G, Pagano E, Barba M, Cicione C, Salonna G, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med. 2014;25(10):2445–61.PubMedPubMedCentralCrossRef Campana V, Milano G, Pagano E, Barba M, Cicione C, Salonna G, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med. 2014;25(10):2445–61.PubMedPubMedCentralCrossRef
29.
go back to reference Berner A, Reichert JC, Woodruff MA, Saifzadeh S, Morris AJ, Epari DR, et al. Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical sized segmental tibial bone defects in aged sheep. Acta Biomater. 2013;9(8):7874–84.PubMedCrossRef Berner A, Reichert JC, Woodruff MA, Saifzadeh S, Morris AJ, Epari DR, et al. Autologous vs. allogenic mesenchymal progenitor cells for the reconstruction of critical sized segmental tibial bone defects in aged sheep. Acta Biomater. 2013;9(8):7874–84.PubMedCrossRef
30.
go back to reference Guo SQ, Xu JZ, Zou QM, Jiang DM. Immunological study of allogeneic mesenchymal stem cells during bone formation. J Int Med Res. 2009;37(6):1750–9.PubMedCrossRef Guo SQ, Xu JZ, Zou QM, Jiang DM. Immunological study of allogeneic mesenchymal stem cells during bone formation. J Int Med Res. 2009;37(6):1750–9.PubMedCrossRef
31.
go back to reference Schoenau E, Neu CM, Rauch F, Manz F. The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab. 2001;86(2):613–8.PubMedCrossRef Schoenau E, Neu CM, Rauch F, Manz F. The development of bone strength at the proximal radius during childhood and adolescence. J Clin Endocrinol Metab. 2001;86(2):613–8.PubMedCrossRef
32.
go back to reference Cottrell JA, Turner JC, Arinzeh TL, O’Connor JP. The biology of bone and ligament healing. Foot Ankle Clin. 2016;21(4):739–61.PubMedCrossRef Cottrell JA, Turner JC, Arinzeh TL, O’Connor JP. The biology of bone and ligament healing. Foot Ankle Clin. 2016;21(4):739–61.PubMedCrossRef
33.
go back to reference Di Bella C, Aldini NN, Lucarelli E, Dozza B, Frisoni T, Martini L, et al. Osteogenic protein-1 associated with mesenchymal stem cells promote bone allograft integration. Tissue Eng Part A. 2010;16(9):2967–76.PubMedCrossRef Di Bella C, Aldini NN, Lucarelli E, Dozza B, Frisoni T, Martini L, et al. Osteogenic protein-1 associated with mesenchymal stem cells promote bone allograft integration. Tissue Eng Part A. 2010;16(9):2967–76.PubMedCrossRef
34.
go back to reference Field JR, McGee M, Stanley R, Ruthenbeck G, Papadimitrakis T, Zannettino A, et al. The efficacy of allogeneic mesenchymal precursor cells for the repair of an ovine tibial segmental defect. Vet Comp Orthop Traumatol. 2011;24(2):113–21.PubMedCrossRef Field JR, McGee M, Stanley R, Ruthenbeck G, Papadimitrakis T, Zannettino A, et al. The efficacy of allogeneic mesenchymal precursor cells for the repair of an ovine tibial segmental defect. Vet Comp Orthop Traumatol. 2011;24(2):113–21.PubMedCrossRef
35.
go back to reference Berner A, Henkel J, Woodruff MA, Saifzadeh S, Kirby G, Zaiss S, et al. Scaffold-cell bone engineering in a validated preclinical animal model: precursors vs differentiated cell source. J Tissue Eng Regen Med. 2017;11(7):2081–9.PubMedCrossRef Berner A, Henkel J, Woodruff MA, Saifzadeh S, Kirby G, Zaiss S, et al. Scaffold-cell bone engineering in a validated preclinical animal model: precursors vs differentiated cell source. J Tissue Eng Regen Med. 2017;11(7):2081–9.PubMedCrossRef
36.
go back to reference Berner A, Henkel J, Woodruff MA, Steck R, Nerlich M, Schuetz MA, et al. Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model. Stem Cells Transl Med. 2015;4(5):503–12.PubMedPubMedCentralCrossRef Berner A, Henkel J, Woodruff MA, Steck R, Nerlich M, Schuetz MA, et al. Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model. Stem Cells Transl Med. 2015;4(5):503–12.PubMedPubMedCentralCrossRef
37.
go back to reference Gardel LS, Correia-Gomes C, Serra LA, Gomes ME, Reis RL. A novel bidirectional continuous perfusion bioreactor for the culture of large-sized bone tissue-engineered constructs. J Biomed Mater Res B Appl Biomater. 2013;101(8):1377–86.PubMedCrossRef Gardel LS, Correia-Gomes C, Serra LA, Gomes ME, Reis RL. A novel bidirectional continuous perfusion bioreactor for the culture of large-sized bone tissue-engineered constructs. J Biomed Mater Res B Appl Biomater. 2013;101(8):1377–86.PubMedCrossRef
38.
go back to reference Gardel LS, Serra LA, Reis RL, Gomes ME. Use of perfusion bioreactors and large animal models for long bone tissue engineering. Tissue Eng Part B Rev. 2014;20(2):126–46.PubMedCrossRef Gardel LS, Serra LA, Reis RL, Gomes ME. Use of perfusion bioreactors and large animal models for long bone tissue engineering. Tissue Eng Part B Rev. 2014;20(2):126–46.PubMedCrossRef
Metadata
Title
Autologous cell-coated particles for the treatment of segmental bone defects—a new cell therapy approach
Authors
Dror Ben-David
Bettina Fishman
Guy Rubin
Atara Novak
Ilana Laevsky
Avinoam Kadouri
Yasmin Nishri Katz
Ora Burger
Asaph Zaretsky
Noam Bor
Ephraim Tzur
Shai Meretzki
Nimrod Rozen
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Bone Defect
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2019
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-019-1219-5

Other articles of this Issue 1/2019

Journal of Orthopaedic Surgery and Research 1/2019 Go to the issue